- Home
- GERN vs AZZ Comparison
GERN vs AZZ Comparison
Compare GERN & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- AZZ
- Stock Information
- Founded
- GERN 1990
- AZZ 1956
- Country
- GERN United States
- AZZ United States
- Employees
- GERN N/A
- AZZ N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- AZZ Industrial Specialties
- Sector
- GERN Health Care
- AZZ Industrials
- Exchange
- GERN Nasdaq
- AZZ Nasdaq
- Market Cap
- GERN 974.5M
- AZZ 2.7B
- IPO Year
- GERN 1996
- AZZ N/A
- Fundamental
- Price
- GERN $1.43
- AZZ $99.62
- Analyst Decision
- GERN Buy
- AZZ Buy
- Analyst Count
- GERN 7
- AZZ 6
- Target Price
- GERN $4.17
- AZZ $104.00
- AVG Volume (30 Days)
- GERN 9.7M
- AZZ 213.6K
- Earning Date
- GERN 08-07-2025
- AZZ 07-09-2025
- Dividend Yield
- GERN N/A
- AZZ 0.68%
- EPS Growth
- GERN N/A
- AZZ N/A
- EPS
- GERN N/A
- AZZ 1.79
- Revenue
- GERN $116,293,000.00
- AZZ $1,577,744,000.00
- Revenue This Year
- GERN $160.12
- AZZ $7.62
- Revenue Next Year
- GERN $55.01
- AZZ $3.24
- P/E Ratio
- GERN N/A
- AZZ $55.65
- Revenue Growth
- GERN 22264.04
- AZZ 2.61
- 52 Week Low
- GERN $1.17
- AZZ $69.59
- 52 Week High
- GERN $5.06
- AZZ $101.43
- Technical
- Relative Strength Index (RSI)
- GERN 46.80
- AZZ 69.94
- Support Level
- GERN $1.34
- AZZ $86.67
- Resistance Level
- GERN $1.57
- AZZ $95.92
- Average True Range (ATR)
- GERN 0.10
- AZZ 2.32
- MACD
- GERN -0.02
- AZZ 0.95
- Stochastic Oscillator
- GERN 37.50
- AZZ 87.74
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.